Australia seems poised to welcome innovative treatment for obesity: Retatrutide. The dual compound – acting on both GLP-1 and GIP receptors – shows promising results in global research, indicating considerable drops in weight. While regulatory clearance hasn't occurred with Australian regulators, many people battling obesity might hoping for Re